FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ewert Schulte-Frohlinde

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Co-author Network

Publications

TOP 3
Ewert Schulte-Frohlinde
[Elevated liver enzymes--what to do and when].
Andreas Rieger; Ewert Schulte-Frohlinde; Jörg Nährig; Jeannine Bachmann; Michael Burzin; Helmut Friess; Marc E Martignoni
Total gastric necrosis subsequent to acute pancreatitis.
Christoph Sarrazin; Ewert Schulte-Frohlinde; Susanne Schwendy; Gerlinde Teuber; Robert Thimme; Stefan Zeuzem; Wulf O Boecher; Peter Buggisch; Nektarios Dikopoulos; Jens Encke; Tobias Goeser; Eva Herrmann; Hartwig Klinker; Bernd Möller; Renate Prinzing; Thomas Berg
Improved responses to pegylated interferon alfa-2b and ribavirin by individualizing treatment for 24-72 weeks.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ewert Schulte-Frohlinde (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Ewert Schulte-Frohlinde
[Elevated liver enzymes--what to do and when].
MMW Fortschritte der Medizin 2012;154(21):65-9; quiz 70.
2012: Andreas Rieger; Ewert Schulte-Frohlinde; Jörg Nährig; Jeannine Bachmann; Michael Burzin; Helmut Friess; Marc E Martignoni
Total gastric necrosis subsequent to acute pancreatitis.
Pancreas 2012;41(2):325-7.
2011: Christoph Sarrazin; Ewert Schulte-Frohlinde; Susanne Schwendy; Gerlinde Teuber; Robert Thimme; Stefan Zeuzem; Wulf O Boecher; Peter Buggisch; Nektarios Dikopoulos; Jens Encke; Tobias Goeser; Eva Herrmann; Hartwig Klinker; Bernd Möller; Renate Prinzing; Thomas Berg
Improved responses to pegylated interferon alfa-2b and ribavirin by individualizing treatment for 24-72 weeks.
Gastroenterology 2011;141(5):1656-64.
2010: T Sternfeld; V Spöri-Byrtus; C Riediger; R Langer; Helmut Friess; Roland M Schmid; Ewert Schulte-Frohlinde
Acute measles infection triggering an episode of liver transplant rejection.
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2010;14(6):e528-30.
2010: Andreas Weber; Stephanie Krebs; Cosima Lenhardt; Stefan Wagenpfeil; Roland M Schmid; Ewert Schulte-Frohlinde
Reply from the authors.
Hepatology research : the official journal of the Japan Society of Hepatology 2010;40(5):555.
2009: Andreas Weber; Stephanie Krebs; Cosima Lenhardt; Stefan Wagenpfeil; Roland M Schmid; Ewert Schulte-Frohlinde
Correlation of routinely used coagulation parameters and presence of portal vein thrombosis in patients with liver cirrhosis.
Hepatology research : the official journal of the Japan Society of Hepatology 2009;39(9):882-7.
2009: Stefan von Delius; Philipp Thies; Thomas Rieder; Stefan Wagenpfeil; Esther Herberich; A Karagianni; Eckart Frimberger; Alexander Meining; Leopold Ludwig; Matthias P A Ebert; Ewert Schulte-Frohlinde; Bruno Neu; Christian Prinz; Roland M Schmid; Wolfgang Huber
Auditory evoked potentials compared with bispectral index for monitoring of midazolam and propofol sedation during colonoscopy.
The American journal of gastroenterology 2009;104(2):318-25.
2009: Andreas Weber; Christian Prinz; Carlos Gerngross; Leopold Ludwig; Wolfgang Huber; Bruno Neu; Matthias P A Ebert; Alexander Meining; Hans Weidenbach; Roland M Schmid; Ewert Schulte-Frohlinde
Long-term outcome of endoscopic and/or percutaneous transhepatic therapy in patients with biliary stricture after orthotopic liver transplantation.
Journal of gastroenterology 2009;44(12):1195-202.
2008: Ewert Schulte-Frohlinde
[Isolated enhancement of gamma-GT].
Der Internist 2008;49(12):1526.
2007: Stefan von Delius; Christian Lersch; Martina Mayr; K Stock; Ewert Schulte-Frohlinde; Roland M Schmid; Florian Eckel
Capecitabine for treatment of advanced hepatocellular carcinoma.
Hepato-gastroenterology 2007;54(80):2310-4.
2007: Ewert Schulte-Frohlinde; Stefan Wagenpfeil; Johanna Willis; Christian Lersch; Florian Eckel; Roland Schmid; Volker Schusdziarra
Role of meal carbohydrate content for the imbalance of plasma amino acids in patients with liver cirrhosis.
Journal of gastroenterology and hepatology 2007;22(8):1241-8.
2007: Claudia Hillerer; Ewert Schulte-Frohlinde; M Dobritz; Jochen Gaa
[Focal nodular liver lesions associated with a congenital portocaval shunt in an adult woman].
Der Radiologe 2007;47(2):163-4, 166.
2006: Peter B Luppa; Markus Thaler; Ewert Schulte-Frohlinde; Anita Schreiegg; Ursula Huber; Jochen Metzger
Unchanged androgen-binding properties of sex hormone-binding globulin in male patients with liver cirrhosis.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2006;44(8):967-73.
2006: Stefan von Delius; Christian Lersch; Ewert Schulte-Frohlinde; F Fend; M Dobritz; Roland M Schmid; Florian Eckel
Hepatocellular carcinoma associated with hereditary hemochromatosis occurring in non-cirrhotic liver.
Zeitschrift für Gastroenterologie 2006;44(1):39-42.
2005: Florian Eckel; Stefan von Delius; M Mayr; M Dobritz; F Fend; Christian Hosius; E Schleyer; Ewert Schulte-Frohlinde; Roland M Schmid; Christian Lersch
Pharmacokinetic and clinical phase II trial of imatinib in patients with impaired liver function and advanced hepatocellular carcinoma.
Oncology 2005;69(5):363-71.
2005: Stefan von Delius; Christian Lersch; Ewert Schulte-Frohlinde; Martina Mayr; Roland M Schmid; Florian Eckel
Phase II trial of weekly 24-hour infusion of gemcitabine in patients with advanced gallbladder and biliary tract carcinoma.
BMC cancer 2005;5():61.
2004: Christian Lersch; Renate Schmelz; J Erdmann; R Hollweck; Ewert Schulte-Frohlinde; Florian Eckel; M Nader; V Schusdziarra
Treatment of HCC with pravastatin, octreotide, or gemcitabine--a critical evaluation.
Hepato-gastroenterology 2004;51(58):1099-103.
2002: Florian Eckel; Christian Lersch; Florian Lippl; Ewert Schulte-Frohlinde; Volker Schusdziarra; Hermann Helmberger; J Neverve; M Decker; R Frank; M Schwaiger; W Weber
Monitoring of tumour glucose metabolism by PET in a phase I study evaluating hormonal therapy in advanced pancreatic cancer.
Scandinavian journal of gastroenterology 2002;37(8):972-7.
2002: Christian Lersch; Renate Schmelz; Florian Eckel; Johannes Erdmann; Martina Mayr; Ewert Schulte-Frohlinde; Stefan Quasthoff; Julian Grosskreutz; Helmuth Adelsberger
Prevention of oxaliplatin-induced peripheral sensory neuropathy by carbamazepine in patients with advanced colorectal cancer.
Clinical colorectal cancer 2002;2(1):54-8.
2002: Ewert Schulte-Frohlinde; Barbara Seidler; Ines Burkard; Tobias Freilinger; Christian Lersch; Volker Erfle; Graham R Foster; Meinhard Classen
Different activities of type I interferons on hepatitis B virus core promoter regulated transcription.
Cytokine 2002;17(4):214-20.
2002: Florian Eckel; Christian Lersch; Gerald Assmann; Ewert Schulte-Frohlinde
Toxicity of a 24-hour infusion of gemcitabine in biliary tract and pancreatic cancer: a pilot study.
Cancer investigation 2002;20(2):180-5.
2000: Florian Eckel; Christian Lersch; Florian Lippl; Gerald Assmann; Ewert Schulte-Frohlinde
Phase II trial of cyclophosphamide, leucovorin, 5-fluorouracil 24-hour infusion and tamoxifen in pancreatic cancer.
Journal of experimental & clinical cancer research : CR 2000;19(3):295-300.
2000: Florian Eckel; Christian Lersch; J Erdmann; B Schmidt; Ewert Schulte-Frohlinde
[A 42-year-old patient with the hemolytic-uremic syndrome under gemcitabine therapy for an adenocarcinoma of the liver. The hemolytic-uremic syndrome and gemcitabine].
Zeitschrift für Gastroenterologie 2000;38(7):593-6.
2000: Florian Eckel; Christian Lersch; Gerald Assmann; Ewert Schulte-Frohlinde
Phase II trial of low-dose cyclophosphamide, leucovorin, high-dose 5-fluorouracil 24-hour continuous infusion and tamoxifen in advanced biliary tract cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(6):762-3.
2000: B Marstaller; Christian Lersch; H Berger; Hermann Helmberger; P Hellerhoff; Ewert Schulte-Frohlinde
[Hepatocellular carcinoma with extension per continuitatem into the right atrium].
Deutsche medizinische Wochenschrift (1946) 2000;125(13):391-4.
2000: Ewert Schulte-Frohlinde; Wolfgang Reindl; D Bierling; Christian Lersch; V Brantl; Hansjörg Teschemacher; Volker Schusdziarra
Effects of oral casokefamide on plasma levels, tolerance, and intestinal transit in man.
Peptides 2000;21(3):439-42.
2000: Florian Eckel; Christian Lersch; Wolfgang Huber; W Weiss; H Berger; Ewert Schulte-Frohlinde
Multimicrobial sepsis including Clostridium perfringens after chemoembolization of a single liver metastasis from common bile duct cancer.
Digestion 2000;62(2-3):208-12.
1999: Christian Lersch; Florian Eckel; Robert Sader; Makarios Paschalidis; F Zeilhofer; Ewert Schulte-Frohlinde; Wolfram Theiss
Initial experience with Healthport miniMax and other peripheral arm ports in patients with advanced gastrointestinal malignancy.
Oncology 1999;57(4):269-75.
1998: Ewert Schulte-Frohlinde; S Schmolke; Wolfgang Reindl; G Schätzle; J Scherf; K F Kopp; M Classen; V Schlüter
Significance of antibodies to the recombinant E2 protein of hepatitis G virus in haemodialysis patients.
Journal of viral hepatitis 1998;5(5):341-4.
1998: Ewert Schulte-Frohlinde; Graham R Foster
Spontaneous seroconversion in chronic hepatitis B: role of mutations in the precore/core gene.
Digestive diseases and sciences 1998;43(8):1714-8.